Alemtuzumab

Results: 47



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA® (alemtuzumab) injection,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA® (alemtuzumab) injection,

Add to Reading List

Source URL: products.sanofi.us

- Date: 2016-09-14 13:21:08
    2Allogeneic hematopoietic SCT for patients with autoimmune diseases

    Allogeneic hematopoietic SCT for patients with autoimmune diseases

    Add to Reading List

    Source URL: www.nature.com

    Language: English - Date: 2010-01-13 06:38:42
    3UCT T-CELL DEPLETION: ALEMTUZUMAB IN THE BAG Nicolas Novitzky PhD, FCP(SA)

    UCT T-CELL DEPLETION: ALEMTUZUMAB IN THE BAG Nicolas Novitzky PhD, FCP(SA)

    Add to Reading List

    Source URL: www.wbmt.org

    Language: English - Date: 2014-11-18 18:00:00
      4alemtuzumab (Lemtrada) Ordnat Införande i Samverkan DatumVersion 2.0 Ett samarbetsprojekt mellan Sveriges landsting & Regioner Alemtuzumab (Lemtrada) vid skovvis förlöpande MS

      alemtuzumab (Lemtrada) Ordnat Införande i Samverkan DatumVersion 2.0 Ett samarbetsprojekt mellan Sveriges landsting & Regioner Alemtuzumab (Lemtrada) vid skovvis förlöpande MS

      Add to Reading List

      Source URL: www.janusinfo.se

      Language: Swedish - Date: 2014-05-06 05:07:31
        5Pharmacology / Medicine / Natalizumab / Alemtuzumab / Fingolimod / Clinical trial / Immunosuppressants / Immunology / Multiple sclerosis

        7.10 ALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). Purpose of Application

        Add to Reading List

        Source URL: www.pbs.gov.au

        Language: English - Date: 2015-03-16 01:05:14
        6Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1

        Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1

        Add to Reading List

        Source URL: www.pbs.gov.au

        Language: English - Date: 2015-03-16 01:05:14
        7idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015

        idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015

        Add to Reading List

        Source URL: www.scottishmedicines.org.uk

        Language: English
        8MEDICATION GUIDE LEMTRADA™ (lem-TRA-da) (alemtuzumab) Injection for intravenous infusion Rx Only

        MEDICATION GUIDE LEMTRADA™ (lem-TRA-da) (alemtuzumab) Injection for intravenous infusion Rx Only

        Add to Reading List

        Source URL: products.sanofi.us

        Language: English - Date: 2014-12-11 14:21:38
        9JOHN C. BYRD, MD Office Address: Mailing Address: Office: Fax: Lab:

        JOHN C. BYRD, MD Office Address: Mailing Address: Office: Fax: Lab:

        Add to Reading List

        Source URL: osuwmcdigital.osu.edu

        Language: English - Date: 2014-05-01 10:48:22
        10PRESS RELEASE Genzyme’s Lemtrada Approved by the FDA - Approval Establishes Genzyme’s MS Franchise in the U.S. with Two Approved Products; Follows Global Approvals Paris - November 15, [removed]Sanofi and its subsidia

        PRESS RELEASE Genzyme’s Lemtrada Approved by the FDA - Approval Establishes Genzyme’s MS Franchise in the U.S. with Two Approved Products; Follows Global Approvals Paris - November 15, [removed]Sanofi and its subsidia

        Add to Reading List

        Source URL: www.sanofi.hk

        Language: English